Belgium· BE-AMP-SAM532657-00
Biktarvy 50 mg - 200 mg - 25 mg
A emtricitabine, tenofovir alafenamide and bictegravir product containing emtricitabine, registered in Belgium by Gilead Sciences Ireland UC. The same ATC class is registered in 13 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Emtricitabine, tenofovir alafenamide and bictegravir is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AR20 (emtricitabine, tenofovir alafenamide and bictegravir), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Emtricitabine, tenofovir alafenamide and bictegravir · ATC J05AR20
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Emtricitabine
- Manufacturer
- Gilead Sciences Ireland UC
- Country
- Belgium (BE)
- ATC code
- J05AR20
- ATC class
- Emtricitabine, tenofovir alafenamide and bictegravir
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 11
7 priced- be_apb4502050EUR 858.71
- be_apb3774676EUR 858.71
- be_apb4160511EUR 858.71
- be_apb7723935
- be_apb4272142EUR 794.01
- be_apb7730633
- be_apb7727456
- be_apb7748163
- be_apb4981411EUR 858.71
- be_apb4981387EUR 858.71
- be_apb4404851EUR 858.71
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Emtricitabine, tenofovir alafenamide and bictegravir in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesemtricitabineCipla USA Inc.
- IrelandEmtricitabine/Tenofovir alafenamide Viatris 200 mg/10 mg film-coated tabletsViatris Limited
- CzechiaEMTRIVAGilead Sciences Ireland UC, Carrigtohill
- FinlandEmtrivaOrifarm Oy
- United KingdomEmtriva 10mg/ml oral solutionGilead Sciences Ltd
- NetherlandsEmtriva 10 mg/ml, drankGilead Sciences Ireland UC
- IcelandEmtrivaGilead Sciences Ireland UC*
- SpainEMTRIVA 10 MG/ML SOLUCION ORALGilead Sciences Ireland Unlimited Company
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Spain · Emtricitabina/Tenofovir Alafenamida Dr. Reddys
- Iceland · Emtriva
- Liechtenstein · Emtriva
- Norway · Emtriva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2ab0a0b2-b4ba-4016-89c5-0df3cc1bb7c3 GET /v1/drugs/2ab0a0b2-b4ba-4016-89c5-0df3cc1bb7c3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Biktarvy 50 mg - 200 mg - 25 mg",
"name_fr": "Biktarvy 50 mg - 200 mg - 25 mg",
"name_nl": "Biktarvy 50 mg - 200 mg - 25 mg",
"amp_code": "SAM532657-00",
"strengths": [
"200.0000",
"200.0000",
"25.0000",
"50.0000",
"50.0000",
"25.0000"
],
"pack_count": 9,
"substances": [
"Emtricitabine",
"Tenofovir Alafenamide Fumarate",
"Bictegravir Sodium",
"Tenofovir Alafenamide",
"Bictegravir"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Emtricitabine, Tenofovir Alafenamide and Bictegravir",
"authorisation_numbers": [
"EU/1/18/1289/001",
"EU/1/18/1289/002",
"EU/1/18/1289/003",
"EU/1/18/1289/004"
]
}See everything about emtricitabine, tenofovir alafenamide and bictegravir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.